Development · 25 Sep 2026

Life insurance stocks fell up to 10% after the insurance regulator, IRDAI, released a consultation paper on commissions, Expenses of Management (EoM), and distribution reform that proposes to cut commissions payout across products.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

businesstoday.in24 Sep 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Life Insurance Corporation of India

₹391.85

▼ -0.85%

Close (EOD), as of 1 Oct 2026 · source

Life Insurance Corporation of India: results, dividends, orders, the full cited record →

More on Life Insurance Corporation of India

JPMorgan outlined a clear pecking order among listed insurers, placing SBI Life at the top of its preference list, followed by HDFC Life, Max Financial Services, ICICI Lombard, ICICI Prudential Life, and Life Insurance Corporation of India.

29 Sep 2026 · 1 publisher

The trading window for dealing in equity shares of the Life Insurance Corporation of India will be closed for insiders from April 01, 2025, until 48 hours after the conclusion of the Board Meeting for the consideration and approval of financial results for the quarter and year ending March 31, 2025.

28 Sep 2026 · 1 publisher

The National Stock Exchange allocated 37,793,739 equity shares at ₹1,785 per share, aggregating to ₹6,746.18 crore, to 189 investors in its anchor book.

19 Sep 2026 · 1 publisher

ICICI Prudential Mutual Fund and SBI MF together acquired nearly 423.9 million shares worth Rs 17,145 crore in Life Insurance Corporation of India’s offer for sale in August.

16 Sep 2026 · 1 publisher

Bond FRA volumes among private life insurers have fallen nearly 16 per cent during the financial year 2026-27, while the Life Insurance Corporation of India has partly offset the decline.

14 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.